A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be a cost-effective treatment option for the NHS in treating moderate and severe forms of depression ...
Jan 27, 2026
0
1
About one in three older adults fall each year, which often leads to broken bones, hip fractures, and other injuries that can contribute to a marked decline in their quality of life and leads to over $50 billion in medical ...
Jan 28, 2026
0
0
Ahab hunting down Moby Dick. Wile E. Coyote chasing the Road Runner. Learning Latin. Walking over hot coals. Standing in a long line for boba tea or entrance to a small, overpriced clothing retail store. Forking up for luxury ...
Jan 28, 2026
0
7
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (IOP) daily. The current tools for IOP measurement are not portable, convenient, easily accessible, or ...
Jan 27, 2026
0
28
One of the world's most extensive birth cohorts is now entering later adulthood. At the University of Oulu in Finland, the Northern Finland Birth Cohort 1966 (NFBC1966) is launching a major new follow-up combining decades ...
Jan 24, 2026
0
0
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the precision and comfort of cancer therapy. Designed by a team of researchers from China, this smart ...
After a cardiac arrest, families and doctors are often faced with agonizing uncertainty about a patient's chances of recovery. This uncertainty is even greater in hospitals with limited resources, where access to advanced ...
Jan 26, 2026
0
0
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients.
Jan 30, 2026
0
27
Women with cervical cancer who experience significant muscle loss during treatment die at six times the rate of those who maintain muscle mass, according to an international review of 23 studies involving more than 4,000 ...
Jan 24, 2026
0
0
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses ...
Jan 26, 2026
0
47
